Engineered nanoparticles (ENM) cause lung pathology by increasing lysosomal membrane permeability and activation of the NLRP3 inflammasome in macrophages (Q24825716)
Jump to navigation
Jump to search
abstract published in 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Engineered nanoparticles (ENM) cause lung pathology by increasing lysosomal membrane permeability and activation of the NLRP3 inflammasome in macrophages |
abstract published in 2013 |
Statements
Engineered nanoparticles (ENM) cause lung pathology by increasing lysosomal membrane permeability and activation of the NLRP3 inflammasome in macrophages (English)
1 reference
1 reference
25 September 2023
2 references
29 March 2020
Identifiers
1 reference
21 June 2020